Ocular Therapeutix Inc [OCUL] stock prices are up 3.96% to $8.13 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The OCUL shares have gain 3.70% over the last week, with a monthly amount drifted -7.19%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, TD Cowen upgraded its rating to Buy on June 20, 2024, and elevated its price target to $11. BofA Securities started tracking the stock assigning a Buy rating and suggested a price target of $15 on February 09, 2024. Robert W. Baird initiated its recommendation with a Outperform and recommended $18 as its price target on April 21, 2023. In a note dated August 10, 2021, H.C. Wainwright upgraded an Buy rating on this stock but restated the target price of $17.
The stock price of Ocular Therapeutix Inc [OCUL] has been fluctuating between $4.06 and $11.77 over the past year. Currently, Wall Street analysts expect the stock to reach $17 within the next 12 months. Ocular Therapeutix Inc [NASDAQ: OCUL] shares were valued at $8.13 at the most recent close of the market. An investor can expect a potential return of 109.1% based on the average OCUL price forecast.
Analyzing the OCUL fundamentals
The Ocular Therapeutix Inc [NASDAQ:OCUL] reported sales of 61.44M for trailing twelve months, representing a surge of 2.28%. Gross Profit Margin for this corporation currently stands at 0.91% with Operating Profit Margin at -2.3%, Pretax Profit Margin comes in at -2.84%, and Net Profit Margin reading is -2.84%. To continue investigating profitability, this company’s Return on Assets is posted at -0.36, Equity is -0.57 and Total Capital is -0.31. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.21.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 7.79 points at the first support level, and at 7.45 for the second support level. However, for the 1st resistance point, the stock is sitting at 8.39, and for the 2nd resistance point, it is at 8.65.
Ratios To Look Out For
It’s worth pointing out that Ocular Therapeutix Inc [NASDAQ:OCUL]’s Current Ratio is 13.01. In addition, the Quick Ratio stands at 12.94 and the Cash Ratio stands at 11.75. Considering the valuation of this stock, the price to sales ratio is 20.80, the price to book ratio is 3.62.
Transactions by insiders
Recent insider trading involved Notman Donald, that happened on Feb 04 ’25 when 11119.0 shares were sold., Notman Donald completed a deal on Jan 31 ’25 to sell 6301.0 shares. Meanwhile, Officer DONALD D NOTMAN JR. bought 11119.0 shares on Feb 04 ’25.
